389 related articles for article (PubMed ID: 30149506)
1. Consequences of BMPR2 Deficiency in the Pulmonary Vasculature and Beyond: Contributions to Pulmonary Arterial Hypertension.
Andruska A; Spiekerkoetter E
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149506
[TBL] [Abstract][Full Text] [Related]
2. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
3. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
5. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
6. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
7. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
8. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
9. BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.
Ghigna MR; Guignabert C; Montani D; Girerd B; Jaïs X; Savale L; Hervé P; Thomas de Montpréville V; Mercier O; Sitbon O; Soubrier F; Fadel E; Simonneau G; Humbert M; Dorfmüller P
Eur Respir J; 2016 Dec; 48(6):1668-1681. PubMed ID: 27811071
[TBL] [Abstract][Full Text] [Related]
10. Impaired Interleukin-15 Signaling via
Hilton LR; Rätsep MT; VandenBroek MM; Jafri S; Laverty KJ; Mitchell M; Theilmann AL; Smart JA; Hawke LG; Moore SD; Renaud SJ; Soares MJ; Morrell NW; Ormiston ML
Hypertension; 2022 Nov; 79(11):2493-2504. PubMed ID: 36043416
[TBL] [Abstract][Full Text] [Related]
11. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
[No Abstract] [Full Text] [Related]
12. Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.
Soon E; Crosby A; Southwood M; Yang P; Tajsic T; Toshner M; Appleby S; Shanahan CM; Bloch KD; Pepke-Zaba J; Upton P; Morrell NW
Am J Respir Crit Care Med; 2015 Oct; 192(7):859-72. PubMed ID: 26073741
[TBL] [Abstract][Full Text] [Related]
13. [Heritable pulmonary arterial hypertension].
Eichstaedt CA; Shaukat M; Grünig E
Inn Med (Heidelb); 2024 Jun; 65(6):560-565. PubMed ID: 38771375
[TBL] [Abstract][Full Text] [Related]
14. Novel Advances in Modifying BMPR2 Signaling in PAH.
Dannewitz Prosseda S; Ali MK; Spiekerkoetter E
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374819
[TBL] [Abstract][Full Text] [Related]
15. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
Orriols M; Gomez-Puerto MC; Ten Dijke P
Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
[TBL] [Abstract][Full Text] [Related]
16. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
Prewitt AR; Ghose S; Frump AL; Datta A; Austin ED; Kenworthy AK; de Caestecker MP
J Biol Chem; 2015 Jan; 290(2):960-71. PubMed ID: 25411245
[TBL] [Abstract][Full Text] [Related]
19. FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
Dannewitz Prosseda S; Tian X; Kuramoto K; Boehm M; Sudheendra D; Miyagawa K; Zhang F; Solow-Cordero D; Saldivar JC; Austin ED; Loyd JE; Wheeler L; Andruska A; Donato M; Wang L; Huebner K; Metzger RJ; Khatri P; Spiekerkoetter E
Am J Respir Crit Care Med; 2019 Jan; 199(1):83-98. PubMed ID: 30107138
[TBL] [Abstract][Full Text] [Related]
20. Genetics of pulmonary hypertension.
Best DH; Austin ED; Chung WK; Elliott CG
Curr Opin Cardiol; 2014 Nov; 29(6):520-7. PubMed ID: 25159282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
